CNSI has announced the formation of its new board of directors, following the company’s December 2021 acquisition by investment funds affiliated with global investment firm Carlyle.
The board includes several industry leaders with extensive experience in government technology and health care. Those include Carlyle’s Donna Morea and Lawrence B. Prior III; health care adviser Penny Thompson; and industry executive Tom Weston.
“As a Carlyle portfolio company, CNSI is very pleased to be working with the outstanding team of health and IT industry experts who have joined our new Board of Directors,” said CEO Todd Stottlemyer.
Morea serves as board chair. She is the former president of CGI and has since 2016 served as an operating executive with Carlyle. She also is a trustee of Inova Health System and a chair emerita of the Northern Virginia Technology Council.
“Having worked with Todd Stottlemyer and other CNSI executive leaders throughout my career, I know the team’s drive and commitment to be a trusted partner to their clients, a best place to work, and a good corporate citizen within the community,” Morea said.
In addition to Morea and Stottlemyer, CNSI’s board of directors includes:
- Dayne Baird, managing director at Carlyle, who leads the firm’s efforts in the government services sector
- Michael Echemendia, vice president at Carlyle, with a focus on investments in the aerospace, defense and government services sectors
- Michael Gozycki , managing director at Carlyle, with a focus on a broad range of growth, middle market and large cap technology investments
- Lawrence B. Prior III, Carlyle operating executive with a focus on government services, and the former CEO of CSRA Inc
- Penny Thompson, health care adviser, former chair of the MACPAC Commission and former Centers for Medicare and Medicaid Services deputy director for the Center for Medicaid and CHIP Services
- Tom Weston, former executive vice president and chief financial officer of ECS Federal.
“I am excited for the journey ahead as we work together to further strengthen CNSI’s market-leading products and solutions while also accelerating key investments that will help us bring even greater value and innovation for our state and federal healthcare clients,” Stottlemyer added.
